Results 11 to 20 of about 19,533 (291)

Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia

Dermatology and Therapy, 2023
Introduction This study assessed the levels of compliance to topical minoxidil (TM) among male and female patients with androgenetic alopecia (AGA) and analyzed the factors associated with minoxidil discontinuation.
Zari Shadi
doaj   +2 more sources

Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial

Journal of Dermatological Treatment, 2023
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia is not established.
Mithinkumar Balasundaram, Rashmi Kumari, Sivaranjini Ramassamy   +2 more
doaj   +2 more sources

Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review

Dermatology and Therapy
The minimal adverse-effect profile and positive clinical response of low-dose oral minoxidil (LDOM) have recently caused the drug to gain popularity for the treatment of hair disorders in adults.
Kimberly N. Williams, Chrislene T. Y. Olukoga, Antonella Tosti   +2 more
doaj   +2 more sources

Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial [PDF]

Stem cell research & therapeutics, 2023
Introduction Treatments for AGA have yet to produce satisfactory outcomes and may cause intolerable side effects. Recent studies have reported that adipose tissue-derived stem cell conditioned media (ADSC-CM) could induce hair growth and regeneration ...
Lili Legiawati, Lis Surachmiati Suseno, Irma Bernadette S. Sitohang, Shannaz Nadia Yusharyahya, Jeanne Adiwinata Pawitan, Isabella Kurnia Liem, Trie Kurniawati, Athaya Ardelia, Kanya Paramastri   +8 more
openalex   +2 more sources

Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients

JAMA dermatology, 2022
Importance There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), namely, minoxidil and the two 5-α reductase inhibitors dutasteride and finasteride. Objective To examine the relative efficacy
Aditya Gupta, M. Venkataraman, Mesbah Talukder, Mary A. Bamimore   +3 more
openalex   +3 more sources

Finasteride Side Effects and Post-Finasteride Syndrome in Male Androgenic Alopecia [PDF]

, 2015
Finasteride is in present a relatively frequent prescribed drug for male androgenic alopecia. The adverse effects reported by some patients seem to be notable, consisting of various (physical, mental/ neurological, sexual, etc.) manifestations which are ...
Ioana, Paunica, Maria, Puiu Gabriela, Mihnea, Manea Costin, Mirela, Manea   +3 more
core   +10 more sources

Minoxidil [PDF]

Southern Medical Journal, 1980
Minoxidil (U-10,858) has been shown in several controlled and blind studies and numerous uncontrolled studies to be a potent peripheral vasodilator for use in the management of sustained, severe, accelerating or malignant hypertension and moderate hypertension inadequately controlled by conventional therapy.
openaire   +4 more sources

Clinical efficacy and safety of low‐dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial

Journal of Cosmetic Dermatology, 2023
Topical minoxidil is the recommended first‐line pharmacologic treatment for male and female pattern hair loss. However, low‐dose oral minoxidil has been used off‐label with good clinical efficacy and safety.
A. Asilian, Aida Farmani, Mina Saber
semanticscholar   +1 more source

Dill extract induces elastic fiber neosynthesis and functional improvement in the ascending aorta of aged mice with reversal of age-dependent cardiac hypertrophy and involvement of lysyl oxidase-like-1 [PDF]

, 2020
Elastic fibers (90% elastin, 10% fibrillin-rich microfibrils) are synthesized only in early life and adolescence mainly by the vascular smooth muscle cells through the cross-linking of its soluble precursor, tropoelastin.
Boyle, Walter A, Boëté, Quentin, Cenizo, Valérie, Faury, Gilles, Fhayli, Wassim, Jacob, Marie-Paule, Kihal, Nadjib, Sommer, Pascal   +7 more
core   +3 more sources

Low-dose oral minoxidil for the management of vismodegib-induced alopecia. [PDF]

JAAD Case Rep
Newcomer J, Aghazadeh N.
europepmc   +2 more sources